News and events

News stories

News related to gene therapy at the University of Sheffield and related events.
Bricks being laid at SITraN

New chapter in Sheffield’s world-renowned neuroscience research

New development at the University of Sheffield will double the research capacity of the world-leading research facility, accelerating the progress of breakthrough treatments for neurological diseases such as Parkinson's, Alzheimer's and MND.

Image of motor neurones

Sheffield scientist awarded prestigious prize for ground breaking MND research

Dr Johnathan Cooper-Knock from the University of Sheffield is one of eight outstanding scientists nationwide to receive the 2025 Lister Award in recognition of his pioneering MND research.
Neuron cells system - 3d rendered image of Neuron cell network on black background

University spinout company awarded £2.3 million to develop breakthrough therapies that address underlying causes of MND

Crucible Therapeutics and University of Sheffield secure a £2.3 million Innovate UK Biomedical Catalyst award to develop breakthrough siRNA therapies that address underlying causes of Motor Neuron Disease (MND).
Visual representation Runway Park

Runway Park: A vision for innovation-led growth takes flight

A transformative University of Sheffield development designed to attract investment, create high-quality jobs and accelerate economic growth unveils its new look as Runway Park is officially launched to industry.
DNA strand

FDA approves trial to advance pioneering treatment for Hereditary Spastic Paraplegia (HSP)

The US Food and Drug Administation (FDA) has approved BlackfinBio Limited’s Phase 1/2 clinical trial for its novel adeno-associated virus (AAV) gene therapy targeting Hereditary Spastic Paraplegia (HSP) Type 47 (SPG47).
illustration of DNA molecule

Sheffield researchers help discover previously unidentified genes linked to rare diseases

A landmark study has found 69 previously unidentified genetic determinants of rare disease, including uncommon forms of kidney disease and diabetes.

HRH Princess Anne officially opens the GTIMC at the University of Sheffield

Princess Royal opens pioneering Gene Therapy Innovation and Manufacturing Centre

Her Royal Highness, The Princess Royal, officially opened the Gene Therapy Innovation and Manufacturing Centre (GTIMC) at the University of Sheffield today (2 October 2024).
Professor Dame Pamela Shaw in front of the SITraN building

A career dedicated to treating the ‘cruellest disease’

When the University of Sheffield’s Professor Dame Pamela Shaw first met patients with motor neurone disease (MND), little was known about the devastating condition. Since then, she has dedicated her career to improving the prospects for those living

DNA Molecule

University of Sheffield spinout company to pioneer novel therapies for genetic neurological diseases

BlackfinBio has raised £2.75 million seed investment to advance revolutionary treatments for Hereditary Spastic Paraplegia (HSP).